Progressive age-dependent increases in biofluid NfL have been observed in patients with SCA3, with large increases prior to symptomatic ataxia onset (Wilke et al., 2020b; Li et al., 2019; Peng et al., 2022). This evidence concerns the gene NEFL and Spinocerebellar ataxia type 3.